What Are the Challenges in Assessing Metaphase Disruption?
There are several challenges in assessing metaphase disruption, including the complexity of biological systems and variability in individual responses to toxicants. Additionally, the dose-response relationship can be difficult to establish, as low levels of exposure may not produce detectable effects, yet still pose long-term health risks. Advancements in molecular biology and imaging technologies continue to improve our ability to detect and understand these disruptions.
